OXA-207, a novel OXA-24 variant with reduced catalytic efficiency against carbapenems in Acinetobacter pittii from Spain

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 8, 2014, Pages 4944-4948

  Cayô, Rodrigo ^a,d   Merino, María ^b   Del Castillo, Belén Ruiz ^a   Cano, María Eliecer ^a   Calvo, Jorge ^a   Bou, Germán ^b   Martínez Martínez, Luis ^a,c  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b HOSPITAL JUAN CANALEJO   (Spain)

^c UNIVERSITY OF CANTABRIA   (Spain)

^d FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTAMASE; BETA-LACTAMASE OXA-24; CARBAPENEM DERIVATIVE; INTEGRASE; ISOENZYME; OXACILLIN;

ACINETOBACTER; ACINETOBACTER INFECTIONS; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; BINDING SITE; CHEMISTRY; DRUG EFFECTS; ENZYMOLOGY; GENE EXPRESSION; GENETIC RECOMBINATION; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MOLECULAR CLONING; MOLECULAR GENETICS; SEQUENCE ALIGNMENT; SPAIN;

ACINETOBACTER; ACINETOBACTER INFECTIONS; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; BINDING SITES; CARBAPENEMS; CLONING, MOLECULAR; DRUG RESISTANCE, BACTERIAL; GENE EXPRESSION; HUMANS; INTEGRASES; ISOENZYMES; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; OXACILLIN; RECOMBINATION, GENETIC; SEQUENCE ALIGNMENT; SPAIN;

EID: 84905382215     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02633-13     Document Type: Article

References (27)

1. Nemec A, Krizova L, Maixnerova M, van der Reijden TJ, Deschaght P, Passet V, Vaneechoutte M, Brisse S, Dijkshoorn L. 2011. Genotypic and phenotypic characterization of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex with the proposal of Acinetobacter pittii sp. nov. (formerly Acinetobacter genomic species 3) and Acinetobacter nosocomialis sp. nov. (formerly Acinetobacter genomic species 13TU). Res. Microbiol. 162:393-404. http://dx.doi.org/10.1016/j.resmic.2011.02.006.
2. Chu YW, Leung CM, Houang ET, Ng KC, Leung CB, Leung HY, Cheng AF. 1999. Skin carriage of acinetobacters in Hong Kong. J. Clin. Microbiol. 37:2962-2967.
3. Idzenga D, Schouten MA, van Zanten AR. 2006. Outbreak of Acinetobacter genomic species 3 in a Dutch intensive care unit. J. Hosp. Infect. 63:485-487. http://dx.doi.org/10.1016/j.jhin.2006.03.014.
4. Turton JF, Shah J, Ozongwu C, Pike R. 2010. Incidence of Acinetobacter species other than A. baumannii among clinical isolates of Acinetobacter: evidence for emerging species. J. Clin. Microbiol. 48:1445-1449. http://dx.doi.org/10.1128/JCM.02467-09.
5. Evans BA, Hamouda A, Towner KJ, Amyes SG. 2010. Novel genetic context of multiple blaOXA-58 genes in Acinetobacter genospecies 3. J. Antimicrob. Chemother. 65:1586-1588. http://dx.doi.org/10.1093/jac/dkq180.
6. Wang H, Guo P, Sun H, Wang H, Yang Q, Chen M, Xu Y, Zhu Y. 2007. Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals. Antimicrob. Agents Chemother. 51:4022-4028. http://dx.doi.org/10.1128/AAC.01259-06.
7. Poirel L, Naas T, Nordmann P. 2010. Diversity, epidemiology, and genetics of class D beta-lactamases. Antimicrob. Agents Chemother. 54:24-38. http://dx.doi.org/10.1128/AAC.01512-08.
8. Poirel L, Nordmann P. 2006. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin. Microbiol. Infect. 12:826-836. http://dx.doi.org/10.1111/j.1469-0691.2006.01456.x.
9. Fernández-Cuenca F, Rodríguez-Martínez JM, Gómez-Sánchez MA, de Alba PD, Infante-Martínez V, Pascual A. 2012. Production of a plasmidencoded OXA-72 β-lactamase associated with resistance to carbapenems in a clinical isolate Acinetobacter junii. Int. J. Antimicrob. Agents 39:93-94. http://dx.doi.org/10.1016/j.ijantimicag.2011.07. 017.
10. Mendes RE, Bell JM, Turnidge JD, Castanheira M, Jones RN. 2009. Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY Surveillance Program. J. Antimicrob. Chemother. 63:55-59.
11. Vaneechoutte M, Dijkshoorn L, Tjernberg I, Elaichouni A, de Vos P, Claeys G, Verschraegen G. 1995. Identification of Acinetobacter genomic species by amplified ribosomal DNA restriction analysis. J. Clin. Microbiol. 33:11-15.
12. La Scola B, Gundi VA, Khamis A, Raoult D. 2006. Sequencing of the rpoB gene and flanking spacers for molecular identification of Acinetobacter species. J. Clin. Microbiol. 44:827-832. http://dx.doi.org/10.1128/JCM.44.3.827-832. 2006.
13. Gundi VA, Dijkshoorn L, Burignat S, Raoult D, La Scola B. 2009. Validation of partial rpoB gene sequence analysis for the identification of clinically important and emerging Acinetobacter species. Microbiology 155:2333-2341. http://dx.doi.org/10.1099/mic.0.026054-0.
14. Clinical and Laboratory Standards Institute. 2014. Performance standards for antimicrobial susceptibility testing - 24th ed. Informational supplement M100-S24. Clinical and Laboratory Standards Institute, Wayne, PA.
15. Cayô R, Rodríguez MC, Espinal P, Fernández-Cuenca F, Ocampo-Sosa AA, Pascual A, Ayala JA, Vila J, Martínez-Martínez L. 2011. Analysis of genes encoding penicillin-binding proteins in clinical isolates of Acinetobacter baumannii. Antimicrob. Agents Chemother. 55:5907-5913. http://dx.doi.org/10.1128/AAC.00459-11.
16. Mendes RE, Kiyota KA, Monteiro J, Castanheira M, Andrade SS, Gales AC, Pignatari AC, Tufik S. 2007. Rapid detection and identification of metallo-beta-lactamase-encoding genes by multiplex real-time PCR assay and melt curve analysis. J. Clin. Microbiol. 45:544-547. http://dx.doi.org/10.1128/JCM. 01728-06.
17. Woodford N, Ellington MJ, Coelho JM, Turton JF, Ward ME, Brown S, Amyes SG, Livermore DM. 2006. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int. J. Antimicrob. Agents 27:351-353. http://dx.doi.org/10.1016/j.ijantimicag.2006.01.004.
18. Lopez-Otsoa F, Gallego L, Towner KJ, Tysall L, Woodford N, Livermore DM. 2002. Endemic carbapenem resistance associated with OXA-40 carbapenemase among Acinetobacter baumannii isolates from a hospital in northern Spain. J. Clin. Microbiol. 40:4741-4743. http://dx.doi.org/10.1128/JCM.40.12.4741-4743.2002.
19. D'Andrea MM, Giani T, D'Arezzo S, Capone A, Petrosillo N, Visca P, Luzzaro F, Rossolini GM. 2009. Characterization of pABVA01, a plasmid encoding the OXA-24 carbapenemase from Italian isolates of Acinetobacter baumannii. Antimicrob. Agents Chemother. 53:3528-3533. http://dx.doi.org/10.1128/AAC.00178- 09.
20. Merino M, Acosta J, Poza M, Sanz F, Beceiro A, Chaves F, Bou G. 2010. OXA-24 carbapenemase gene flanked by XerC/XerD-like recombination sites in different plasmids from different Acinetobacter species isolated during a nosocomial outbreak. Antimicrob. Agents Chemother. 54:2724-2727. http://dx.doi.org/10.1128/AAC.01674-09.
21. Santillana E, Beceiro A, Bou G, Romero A. 2007. Crystal structure of the carbapenemase OXA-24 reveals insights into the mechanism of carbapenem hydrolysis. Proc. Natl. Acad. Sci. U. S. A. 104:5354-5359. http://dx.doi.org/10. 1073/pnas.0607557104.
22. Schneider KD, Ortega CJ, Renck NA, Bonomo RA, Powers RA, Leonard DA. 2011. Structures of the class D carbapenemase OXA-24 from Acinetobacter baumannii in complex with doripenem. J. Mol. Biol. 406:583-594. http://dx.doi.org/10.1016/j.jmb.2010.12.042.
23. Clinical and Laboratory Standards Institute. 2012. Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically - 9th ed. Approved standard M7-A9. Clinical and Laboratory Standards Institute, Wayne, PA.
24. Acosta J, Merino M, Viedma E, Poza M, Sanz F, Otero JR, Chaves F, Bou G. 2011. Multidrug-resistant Acinetobacter baumannii harboring OXA-24 carbapenemase, Spain. Emerg. Infect. Dis. 17:1064-1067. http://dx.doi.org/10. 3201/eid/1706.091866.
25. Bou G, Oliver A, Martínez-Beltrán J. 2000. OXA-24, a novel class D beta-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain. Antimicrob. Agents Chemother. 44:1556-1561. http://dx.doi.org/10.1128/AAC.44.6.1556-1561.2000.
26. (Erratum, 50:2280, 2006, doi:10.1128/AAC.00514-06.
27. Héritier C, Poirel L, Aubert D, Nordmann P. 2003. Genetic and functional analysis of the chromosome-encoded carbapenem-hydrolyzing oxacillinase OXA-40 of Acinetobacter baumannii. Antimicrob. Agents Chemother. 47:268-273. http://dx.doi.org/10.1128/AAC.47.1.268-273.2003.